{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:20:44Z","timestamp":1793395244236,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jhep.2017.12.007","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:22:16Z","timestamp":1513171336000},"page":"922-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism"],"prefix":"10.1016","volume":"68","author":[{"given":"Congrong","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Daffis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lucifora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Maadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilario","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf K.","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek V.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Balsitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"William E.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.12.007_b0005","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1021\/jm400815m","article-title":"Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis","volume":"56","author":"Roethle","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2017.12.007_b0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2017.12.007_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2172-8-26","article-title":"Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists","volume":"8","author":"Birmachu","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jhep.2017.12.007_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2172-9-39","article-title":"Comparison of human B cell activation by TLR7 and TLR9 agonists","volume":"9","author":"Hanten","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jhep.2017.12.007_b0025","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2011-04-348839","article-title":"TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway","volume":"118","author":"Oh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2017.12.007_b0030","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.007_b0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.007_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2016.03.008","article-title":"Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus","volume":"130","author":"Isorce","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2017.12.007_b0045","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1053\/j.gastro.2011.02.057","article-title":"Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice","volume":"140","author":"Lutgehetmann","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.007_b0050","doi-asserted-by":"crossref","first-page":"e0169648","DOI":"10.1371\/journal.pone.0169648","article-title":"The Smc5\/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection","volume":"12","author":"Niu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.12.007_b0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2017.12.007_b0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/hep.25608","article-title":"MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.007_b0065","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00933-15","article-title":"Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion","volume":"89","author":"Yan","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.12.007_b0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2017.12.007_b0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.007_b0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsi\u00e8re","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2017.12.007_b0085","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JVI.02415-06","article-title":"The level of viral antigen presented by hepatocytes influences CD8 T-cell function","volume":"81","author":"Gehring","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.12.007_b0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JVI.01779-06","article-title":"Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus","volume":"81","author":"Robek","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.12.007_b0095","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JVI.01990-10","article-title":"Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody","volume":"85","author":"Sastry","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.12.007_b0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","article-title":"Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration","volume":"60","author":"Allweiss","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.007_b0105","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.12.007_b0110","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2017.12.008","article-title":"Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells","volume":"68","author":"Li","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.007_b0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.12.007_b0120","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.12.007_b0125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.12.007_b0130","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.12.007_b0135","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV","volume":"143","author":"Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.007_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29348","article-title":"Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection","author":"Cheng","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.007_b0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.007_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.25954","article-title":"Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B","volume":"57","author":"Fletcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.12.007_b0155","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.12.007_b0160","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jhep.2015.07.014","article-title":"Early inhibition of hepatocyte innate responses by hepatitis B virus","volume":"63","author":"Luangsay","year":"2015","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817324893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817324893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T13:32:44Z","timestamp":1548250364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817324893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0168827817324893"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.12.007","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}